Nordic Nanovector, a biopharmaceutical company developing therapeutics that target haematological cancers, has appointed Erik Skullerud as CEO. He will be based in the company’s office in Zug but will split…
Nordic Nanovector, a biopharmaceutical company developing therapeutics that target haematological cancers, has appointed Erik Skullerud as CEO. He will be based in the company’s office in Zug but will split…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


